Search results
Showing 8071 to 8085 of 8973 results
Pembrolizumab for previously treated metastatic triple negative breast cancer [ID1246]
Discontinued Reference number: GID-TA10295
Discontinued Reference number: GID-TA10196
Nivolumab for small-cell lung cancer after platinum-based chemotherapy [ID1126]
Discontinued Reference number: GID-TA10158
Aumolertinib for untreated EGFR mutation-positive non-small-cell lung cancer [ID4000]
In development Reference number: GID-TA10899 Expected publication date: TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
In development Reference number: GID-TA10555 Expected publication date: TBC
In development Reference number: GID-TA11299 Expected publication date: TBC
Upadacitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3733]
Discontinued Reference number: GID-TA10597
Tralokinumab for treating moderate to severe atopic dermatitis [ID3734]
Discontinued Reference number: GID-TA10596
Discontinued Reference number: GID-NG10289
Workplace health for employees with disabilities and long-term conditions
Discontinued Reference number: GID-PHG58
Discontinued Reference number: GID-NG10396
Discontinued Reference number: GID-NG10384
Intrapartum care for healthy women and babies - angle of episiotomy
Discontinued Reference number: GID-NG10394
Discontinued Reference number: GID-NG10287
Discontinued Reference number: GID-NG10375